 |
市场调查报告书
商品编码
1081218
癌症患者门诊输液市场规模/份额/行业分析2022-2030：产品/用途/疗法/模式/区域前景/增长潜力/竞争市场份额/预测Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product, Application, By Therapy and Mode (Intramuscular, Intravenous, Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030 |
||||||
价格
由于癌症患者人数的增加和全球对癌症治疗研发的兴趣日益浓厚，预计到 2030 年全球癌症患者门诊输液市场将大幅增长。
按产品划分，IV Cannula 部门将在 2021 年产生约 40 亿美元的收入。这主要是由于在临床试验医疗过程中越来越多地采用 IV 插管进行药物注射或血液样本采集。在全球癌症发病率不断上升的背景下，到 2021 年，激素治疗行业的销售额将超过 60 亿美元。提高患者和医生对替代癌症治疗（如激素治疗）益处的认识也是行业增长的主要增长动力。
本报告调查了全球癌症患者门诊输液市场，定义和概述了市场，分析了新型冠状病毒感染（COVID-19）等市场影响因素，并对市场规模进行了变化和预测。类别/地区/主要国家、竞争环境、主要公司概况等。
目录
第一章调查方法
第2章执行摘要
第3章癌症患者门诊输液行业的思考
- 行业分类
- 产业情况
- 行业影响因素
- 生长因子
- 潜在风险和挑战
- 增长潜力分析
- COVID-19：影响分析
- 波特分析
- 竞争形势
- PESTEL 分析
第 4 章癌症患者门诊输液市场：按产品分类
- 主要趋势
- 输液泵
- 静脉组
- IV 插管
- 无针接头
第 5 章癌症患者门诊输液市场：按用途
- 主要趋势
- 肺癌
- 肝癌
- 乳腺癌
- 前列腺癌
- 其他
第 6 章癌症患者门诊输液市场：按治疗方法
- 主要趋势
- 化疗
- 靶向治疗
- 免疫疗法
- 激素疗法
第7章癌症患者门诊输液市场：按模式
- 主要趋势
- 肌肉注射 (IM)
- 静脉注射 (IV)
- 皮下
- 其他
第 8 章癌症患者门诊输液市场：按地区划分
- 主要趋势
- 北美
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东/非洲
第 9 章公司简介
- 策略仪表板
- B. Braun Melsungen AG
- Baxter
- Becton, Dickinson, and Company
- Fresenius Kabi
- ICU Medical, Inc
- IRadimed Corporation
- Nipro Corporation
- Terumo Corporation
- Smiths Medical
- Medtronic PLC
- Roche Diagnostics
- Teleflex, Inc.,
Product Code: 5268
The global outpatient oncology infusion market is expected to register commendable growth by 2030, due in part to the rising prevalence of cancer cases and growing investment interest towards R&D for cancer treatment worldwide.
Outpatient oncology infusion therapy is rapidly emerging as a major component of modern cancer treatment protocols. Infusion therapy refers to procedures where medicine is administered directly into the bloodstream of the patient to shrink or curb the growth of cancer cells.
Outpatient infusion therapies for cancer treatment encompass various services, including hormone therapy, immunotherapy, chemotherapy, and blood transfusions, as well as other infusion treatments the patient may require, like antibiotics, pain medication, and hydration fluids.
The global outpatient oncology infusion market is bifurcated in terms of product, application, therapy, mode, and region.
With respect to product, the outpatient oncology infusion industry is further classified into intravenous sets, infusion pumps, needleless connectors, and IV cannulas.
Of these, the IV cannulas segment registered revenues worth nearly $4 billion in 2021. This was credited largely to a rising adoption of IV cannulas for the infusion of medication or collection of blood samples in investigational medical processes.
Based on application, the outpatient oncology infusion market is segregated into liver cancer, lung cancer, prostate cancer, breast cancer, and others.
The liver cancer segment held a 3.9% share of the overall market in 2021, given the rapid rise in the prevalence of liver cancer, as well as the escalating demand for infusion therapies like targeted therapy or immunotherapy.
In February 2022, for instance, oncologists and surgeons at Penn Medicine's Department of Surgery used adjuvant hepatic artery infusion chemotherapy along with systemic chemotherapy, in order to treat unresectable CLMs (colorectal liver metastases) or mitigate the risk of recurrence among individuals with resected CLMs.
From a therapy perspective, the outpatient oncology infusion industry is categorized into targeted therapy, immunotherapy, chemotherapy, and hormonal therapy. The hormonal therapy segment recorded a remuneration of over $6 billion in 2021, driven by the growing prevalence of cancer across the globe.
Additionally, rising awareness among patients and physicians regarding the benefits of alternative cancer treatments like hormone therapy is a major driver propelling industry growth.
With regard to mode, the overall outpatient oncology infusion market is divided into Intravenous (IV), Intramuscular (IM), Subcutaneous, and other.
In 2021, the intravenous (IV) segment accounted for almost 30.6% of the overall market share due to the rising occurrence of lung cancer, wherein IV solutions act as the primary source of energy for the patients. In addition, increasing rollout of intravenous (IV) products has also elevated the industry outlook.
In March 2022, for instance, a new therapy was approved by the FDA for the treatment of advanced prostate cancer metastasizing within the body. Known as Pluvicto, the therapy was designed to be administered via intravenous infusion, to identify and destroy tumors too small to be noticed through conventional medical imaging techniques.
On the regional front, the Latin America outpatient oncology infusion industry is poised to register a 12.2% CAGR through the forecast time period. This growth is mainly credited to technological advancements in the regional medical domain, and strong market players focus on developing novel and sophisticated outpatient oncology infusion therapies.
Table of Contents
Chapter 1 Methodology
- 1.1 Methodology
- 1.2 Market definitions
- 1.3 Forecast parameters
- 1.4 Data sources
- 1.4.1 Secondary
- 1.4.1.1 Paid sources
- 1.4.1.2 Unpaid sources
- 1.4.2 Primary
- 1.4.1 Secondary
Chapter 2 Executive Summary
- 2.1 Outpatient oncology infusion industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Therapy trends
- 2.1.5 Mode trends
- 2.1.6 Regional trends
Chapter 3 Outpatient Oncology Infusion Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Recent technological advancements in infusion pumps
- 3.3.1.2 Rising prevalence of cancer across the globe
- 3.3.1.3 Surging government initiatives for cancer awareness
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High costs of cancer therapies
- 3.3.2.2 Safety concern associated with the cancer therapy
- 3.3.1 Growth drivers
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By therapy
- 3.4.4 By mode
- 3.5 COVID-19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape, 2021
- 3.8 PESTEL analysis
Chapter 4 Outpatient Oncology Infusion Market, By Product
- 4.1 Key segment trends
- 4.2 Infusion Pumps
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Intravenous Sets
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 IV Cannulas
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5 Needleless Connectors
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Outpatient Oncology Infusion Market, By Application
- 5.1 Key segment trends
- 5.2 Lung Cancer
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Liver Cancer
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Breast Cancer
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Prostate Cancer
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.6 Other
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Outpatient Oncology Infusion Market, By Therapy
- 6.1 Key segment trends
- 6.2 Chemotherapy
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Targeted Therapy
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Immunotherapy
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.5 Hormonal Therapy
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Outpatient Oncology Infusion Market, By Mode
- 7.1 Key segment trends
- 7.2 Intramuscular (IM)
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Intravenous (IV)
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Subcutaneous
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Outpatient Oncology Infusion Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.6 Japan
- 8.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.7 China
- 8.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by mode, 2017 - 2030 (USD Million
- 8.6.6 South Africa
- 8.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by mode, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Strategy dashboard, 2021
- 9.2 B. Braun Melsungen AG
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Baxter
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Becton, Dickinson, and Company
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Fresenius Kabi
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 ICU Medical, Inc
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 IRadimed Corporation
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 Nipro Corporation
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 Terumo Corporation
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Smiths Medical
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Medtronic PLC
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 Roche Diagnostics
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Teleflex, Inc.,
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
Data Tables
- TABLE 1 Outpatient oncology infusion industry 360 degree synopsis, 2017-2030
- TABLE 2 Global outpatient oncology infusion market, 2017-2030 (USD Million)
- TABLE 3 Global outpatient oncology infusion market, by product, 2017-2030 (USD Million)
- TABLE 4 Global outpatient oncology infusion market, by application, 2017-2030 (USD Million)
- TABLE 5 Global outpatient oncology infusion market, by therapy, 2017-2030 (USD Million)
- TABLE 6 Global outpatient oncology infusion market, by mode, 2017-2030 (USD Million)
- TABLE 7 Global outpatient oncology infusion market, by region, 2017-2030 (USD Million)
- TABLE 8 Industry impact forces
- TABLE 9 Infusion pumps market size, by region, 2017-2030 (USD Million)
- TABLE 10 Intravenous sets market size, by region, 2017-2030 (USD Million)
- TABLE 11 IV cannulas market size, by region, 2017-2030 (USD Million)
- TABLE 12 Needleless connectors market size, by region, 2017-2030 (USD Million)
- TABLE 13 Lung cancer market size, by region, 2017-2030 (USD Million)
- TABLE 14 Liver cancer market size, by region, 2017-2030 (USD Million)
- TABLE 15 Breast cancer market size, by region, 2017-2030 (USD Million)
- TABLE 16 Prostate cancer market size, by region, 2017-2030 (USD Million)
- TABLE 17 Others market size, by region, 2017-2030 (USD Million)
- TABLE 18 Chemotherapy market size, by region, 2017-2030 (USD Million)
- TABLE 19 Targeted therapy market size, by region, 2017-2030 (USD Million)
- TABLE 20 Immunotherapy market size, by region, 2017-2030 (USD Million)
- TABLE 21 Hormonal therapy market size, by region, 2017-2030 (USD Million)
- TABLE 22 Intramuscular (IM) market size, by region, 2017-2030 (USD Million)
- TABLE 23 Intravenous (IV) market size, by region, 2017-2030 (USD Million)
- TABLE 24 Others market size, by region, 2017-2030 (USD Million)
- TABLE 25 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 26 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 27 North America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 28 North America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 29 North America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 30 North America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 31 U.S. outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 32 U.S. outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 33 U.S. outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 34 U.S. outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 35 Canada outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 36 Canada outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 37 Canada outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 38 Canada outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 39 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 40 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 41 Europe outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 42 Europe outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 43 Europe outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 44 Europe outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 45 Germany outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 46 Germany outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 47 Germany outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 48 Germany outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 49 UK outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 50 UK outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 51 UK outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 52 UK outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 53 France outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 54 France outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 55 France outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 56 France outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 57 Spain outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 58 Spain outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 59 Spain outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 60 Spain outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 61 Italy outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 62 Italy outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 63 Italy outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 64 Italy outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 65 Asia Pacific outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 66 Asia Pacific outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 67 Asia Pacific outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 68 Asia Pacific outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 69 Asia Pacific outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 70 Japan outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 71 Japan outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 72 Japan outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 73 Japan outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 74 China outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 75 China outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 76 China outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 77 China outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 78 India outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 79 India outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 80 India outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 81 India outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 82 Australia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 83 Australia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 84 Australia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 85 Australia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 86 Latin America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 87 Latin America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 88 Latin America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 89 Latin America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 90 Latin America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 91 Brazil outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 92 Brazil outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 93 Brazil outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 94 Brazil outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 95 Mexico outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 96 Mexico outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 97 Mexico outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 98 Mexico outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 99 MEA outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 100 MEA outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 101 MEA outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 102 MEA outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 103 MEA outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 104 South Africa outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 105 South Africa outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 106 South Africa outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 107 South Africa outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 108 Saudi Arabia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 109 Saudi Arabia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 110 Saudi Arabia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 111 Saudi Arabia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 112 UAE outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 113 UAE outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 114 UAE outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 115 UAE outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
Charts & Figures
- FIG. 1 Industry segmentation
- FIG. 2 Global outpatient oncology infusion market, 2017 - 2030 (USD Million)
- FIG. 3 Growth potential analysis, by product
- FIG. 4 Growth potential analysis, by application
- FIG. 5 Growth potential analysis, by therapy
- FIG. 6 Growth potential analysis, by mode
- FIG. 7 Porter's analysis
- FIG. 8 PESTEL analysis
- FIG. 9 Key segment trends, by product
- FIG. 10 Key segment trends, by application
- FIG. 11 Key segment trends, by therapy
- FIG. 12 Key segment trends, by mode
- FIG. 13 Key regional trends
- FIG. 14 Strategy dashboard, 2021
